facebook
Traded Co logo
Submit

BXP Acquires Life Science Asset In Cambridge For $592M

Property Image
SOLD
$592,000,000

Massachusetts

See Similar Deals
Other271,000 SF
Sold 09/20/2022
the dealdetailscomps
Property Image
SOLD

BXP Acquires Life Science Asset In Cambridge For $592M

125 Broadway, Cambridge, Massachusetts 02142, United States

See Similar Deals
Other271,000 SF
Sold 09/20/2022

Summary

MASSACHUSETTS
Asset Type:Other
Price Per Square Foot:$2,184
Total Square Footage:271,000 SF
Transaction Type:Sale

A life science property located at 125 Broadway in Cambridge, MA was sold for a total price of $592,000,000. The property spans a total of 271,000 square feet, resulting in a price per square foot of $2,185. The sale took place on September 20, 2022, and the buyer was BXP represented by Bryan Koop of their agency. The seller of the property was Biogen.

Summary of transaction details

  • Property Type: Life Science
  • Transaction Amount: $592,000,000
  • Address: 125 Broadway, Cambridge, MA
  • Market: Cambridge, MA
  • Buyer: BXP - Bryan Koop
  • Seller: Biogen
  • Square Footage: 271,000
  • Price per Square Foot: $2,185

Bryan Koop, representing BXP, played a key role as the buyer's representative in this transaction. The sale of the life science property at 125 Broadway demonstrates the strong real estate market in Cambridge, MA.

Players

BUYER

Details

SOLD
IMAGE: Bryan Koop DATE: 09/20/2022 ADDRESS: 125 Broadway MARKET: Cambridge, MA ASSET TYPE: Life Science BUYER: BXP (@BXPBostonProperties) - Bryan Koop (@Koop_bjk) SELLER: Biogen SALE PRICE: $592,000,000 SF: 271,000 ~ PPSF: $2,185

Stay in the Know

Subscribe for insider commercial real estate news, deal highlights, and market insights—delivered straight to your inbox.

By subscribing, you agree to our Terms of Service and Privacy Policy.

Similar Deals

Suggestions
CRE CalculatorAnalyze deals based on income, expenses, and financing. We automatically filled the calculator with data from the deal you are viewing, fill free to modify it to see how it affects the results.
Deal Type
Operating Income
Operating Expenses (Annual)
Net Operating Income (NOI)

$31,573,333.32

Debt Service Coverage Ratio (DSCR)

0.94x

Cap Rate

5.33%

Cash Flow (Annual)-$2,103,250.97
Cash-on-Cash Return-1.27%
Monthly Debt Service$2,806,382.02
Annual Debt Service$33,676,584.29